Table of Contents Table of Contents
Previous Page  2262-2263 / 2605 Next Page
Information
Show Menu
Previous Page 2262-2263 / 2605 Next Page
Page Background

Dose-fractionations determined in dose escalation studies at

NIRS

Are these phase I-II studies sufficient

to establish a new standard of treatment ?